CDKN2A and melanoma: Constitutively activated canonical WNT signaling via β-catenin has been shown to act synergistically with the MAPK pathway, by suppressing the expression of p16INK4A and cooperating with NRAS in the transformation of a melanocytic lesion into melanoma.